MedPath

Evaluation of Usefulness of Bisphosphanate for diffuse sclerosing osteomyelitis of the jaw

Not Applicable
Recruiting
Conditions
Diffuse Sclerosing Osteomyelitis of the jaw
Registration Number
JPRN-UMIN000032089
Lead Sponsor
Hokkaido University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
13
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients diagnosed Anti-resorptive agents-related ONJ 2)Patients who received other bisphosphonate.3)Children of 15 years or under. 4)pregnancy, nursing woman or possibly pregnant woman.5)Patients with severe renal disorders(BUN:=<1.5 upper limit of normal,Cr:=<1.5 upper limit of normal) 6)patients who are contraindications for Voltaren

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath